Use this report to: - Measure a broad understanding of the market for spinal interventional products, as well as the markets for adjacent but complementary products and technologies. - Analyze the market in terms of key product and technology areas, major manufacturers and factors influencing market growth. - Provide a more comprehensive analysis of the overall market and growth opportunities for companies operating in the spinal interventional market. - Discuss major stakeholders, product portfolios and recent developments, and to draw a competitive landscape for the market leaders in the spinal interventional market.
Highlights - The global market for spinal and neurostimulation intervention products is expected to reach $15.8 billion by 2021 from $12.6 billion in 2016, rising at a compound annual growth rate (CAGR) of 4.5% from 2016 through 2021. - The spinal surgery segment of spinal intervention market is the largest sector. The market is expected to grow from $9.0 billion in 2016 to $10.8 billion in 2021 at a CAGR of 3.5% for the period 2016-2021. - The neurostimulation devices segment of spinal intervention market is expected to grow from $3.6 billion in 2016 to $5.0 billion in 2021 at a CAGR of 6.9% for the period 2016-2021.
STUDY GOALS AND OBJECTIVES This report, Spinal Intervention: Markets for Surgical, Replacement and Neurostimulation Technologies, provides an in-depth analysis of the markets for spinal and neurostimulation products. It aims to provide readers with a broad understanding of the market for spinal interventional products, as well as the markets for adjacent but complementary products and technologies.
REASONS FOR DOING THE STUDY In the U.S. alone, back pain has an estimated direct cost of over $50 billion annually for diagnosis, treatment and rehabilitation. Currently, it is estimated that there are approximately 65 million people in the U.S. alone with chronic back pain. The treatment of back pain depends much on the root cause. Generally, pharmaceuticals and/or physical therapy are the first-line treatments. However, should these not work, spinal surgery may be an option for some patients. Currently, over 1 million spinal surgeries are performed each year. Given the aging population, these rates are expected to continue to increase in coming years, leading to a good market opportunity for companies working in this space.
As an alternative to spinal surgery, neurostimulation has become a new option for the treatment of lower back pain in recent years. In addition to treating pain, neurostimulation can be used to treat unwanted neurological or psychological symptoms, as well as to enhance muscular activity. As such, neurostimulation can be used, or is being investigated for use, to treat a wide range of conditions, including chronic migraine, cluster headache, Parkinson’s disease, essential tremor, dystonia, epilepsy, overactive bladder, fecal incontinence, gastroparesis, obesity, gastroesophageal reflux disease, sleep apnea, treatment-resistant hypertension, obsessive-compulsive disorder, depression, heart failure, Alzheimer’s disease, tinnitus and upper-limb deficit after stroke. This is a dynamic and growing market that is attracting increasing interest from manufacturers, surgeons and patients alike.
SCOPE OF REPORT The report provides an analysis of the markets for spinal and neurostimulation products, including trends and sales to 2021. It analyzes the market in terms of key product and technology areas, major manufacturers and factors influencing market growth.
Manufacturers of neurostimulation and spinal technologies are discussed and analyzed based on product types, market share and key corporate activities, including a mergers and acquisitions, strategic alliances, and research and development. In addition to neurostimulation products used for the treatment of spinal conditions, the report looks at the wider neurostimulation industry in order to provide a more comprehensive analysis of the overall market and growth opportunities for companies operating in this field.
The report also includes an in-depth analysis of new products and technologies in development, as well as the development of new products that can address a growing number of therapeutic indications. Excluded from the scope of the report are spinal soft goods, bracing products and externally worn neurostimulation devices.
INTENDED AUDIENCE The report is intended for anyone interested in gaining a better understanding of the spinal implant and neurostimulation markets. This may include company executives working in these areas, those planning or contemplating investing in the market, companies actively or considering pursuing market entry, component or materials manufacturers whose products may be relevant to the industry, suppliers and distributors working in this field. In addition, the report would be of interest to venture capitalists, clinicians, trade associations, research organizations and government bodies with an interest in spinal and neurostimulation products and technologies.
INFORMATION SOURCES The information contained in the report comes from a wide range of primary and secondary sources. Financial and market data are derived from U.S. Securities and Exchange Commission filings, company annual reports and other financial reports, company investor presentations, trade associations, industry associations and company executives. Product and technology sources include company press releases and websites, information from professional organization and industry conferences, medical research papers and medical journal articles, U.S. Patent Office filings and U.S. Food and Drug Administration databases and resources, as well as similar sources available for countries other than the U.S.
Other major sources of information include government bodies such as the U.S. Center of Disease Control and Prevention, the U.S. Department of Health and Human Services and the World Health Organization, as well as similar bodies in other countries. In addition, the report has been complied with the help of direct communication with company executives, including CEOs, product managers, marketing managers, investor relations and research and development staff.
ANALYST'S CREDENTIALS Joanne Maddox is an experienced healthcare industry analyst specializing on the medical device and diagnostics markets. She has 16 years of experience working specifically in this niche area. Her work has included competitor and market insight, due diligence assistance, market forecasting and trend analysis of the medical devices industry, with a key focus on orthopedic and spinal technologies, implantable electronic devices, diagnostics, medical imaging and wound care.
Our reports have been used by over 10K customers, including:
The dental diamond burs market size is projected to grow from USD 130 million in 2021 to USD 191 million by 2026, at a CAGR of 8.0%. The dental diamond burs market is witnessing high growth owing to the increase in the consciousness to dental and oral health and versatility of the dental industry to provide specific and optimum services to...
The global urinalysis market size is projected to reach USD 4.9billion by 2026 from USD 3.5billion in 2021, at a CAGR of 7.2% during the forecast period. Market growth is driven by factors such as increasing burden of UTIs, diabetes, and kidney & liver diseases, rising geriatric population and the subsequent increase in age- associated diseases...
The global physiotherapy equipment market exhibited moderate growth during 2015-2020. Looking forward, the analyst expects the market to grow at a CAGR of around 5% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence...
The sleep apnea devices market is projected to reach USD 9.9 billion by 2026 from USD 7.1 billion in 2021, at a CAGR of 6.9% during the forecast period. Market growth is mainly driven by factors such as the large pool of undiagnosed sleep apnea patients, growing awareness about the ill effects of untreated sleep apnea, growing usage of oral...
Report Scope: This report serves as an ideal guide for the subscribers wishing to understand the oxygenator market extensively in terms of the science behind oxygenators, revenues, technology innovations, key manufacturers and competitors. In this report, the market estimates are provided considering new sales of oxygenator...
Quality Management Software Market Size, Share & Trends Analysis Report By Solution (Complaint Handling, Document Control), By Deployment, By Enterprise Size, By End Use, By Region, And Segment Forecasts, 2021 - 2028
Quality Management Software Market Growth & Trends
The global quality management...
The ablation technology market is projected to reach USD 8.1 Billion by 2026 from USD 5.2 Billion in 2021, at a CAGR of 9.3% during the forecast period. The growing elderly population has also driven the incidence of target conditions and contributed to the demand for effective treatment. However, the reuse and reprocessing of devices in developed...
The global infection surveillance solutions market is to reach USD 1,033 million by 2026 from USD 508 million in 2021, at a CAGR of 15.2%. The growth in this market can primarily be attributed to the increasing incidence of HAIs and increasing surgical procedures. The rising healthcare expenditure, an increasing number of surgeries, the growing...
175 pages •
By The Business Research Company
• Sep 2021
Major players in the community oncology services market are Community Care Physicians P.C., Nebraska Cancer Specialists, US Oncology, Inc. (McKesson Corporation), Tufts Medical Center, Doctors Medical Center, Oncology Specialists, S.C., and Baptist Cancer Center. The global community oncology services market is expected to decline from...
Though in early stages, 5G will be adopted considerably faster than 4G based on the current rate experienced in China and South Korea.However, even with faster adoption rates of 5G, 4G will remain the more prevalent cellular technology through 2025.
The APAC revenue from 5G is expected to grow from $2.13 billion in 2020 to $13.90...
Media And Entertainment
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.